Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

VARIAN MEDICAL SYSTEMS SCANDINAVIA A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   1.1% 1.3% 1.0% 1.0% 1.1% 1.2% 7.6% 7.1%   Credit score (0-100)   85 82 87 86 84 83 31 34   Credit rating   A A A A A A BB BBB   Credit limit (mDKK)   3.5 1.5 8.8 5.8 5.6 3.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   154 354 370 319 251 288 288 288   Gross profit   29.7 50.3 61.9 67.4 53.1 38.4 0.0 0.0   EBITDA   12.9 21.7 27.2 36.7 27.8 13.5 0.0 0.0   EBIT   12.9 21.7 27.2 36.7 27.8 13.5 0.0 0.0   Pre-tax profit (PTP)   7.6 20.6 30.0 36.2 28.7 17.8 0.0 0.0   Net earnings   6.3 16.0 23.4 28.4 22.0 13.4 0.0 0.0   Pre-tax profit without non-rec. items   7.6 20.6 30.0 36.2 28.7 17.8 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Tangible assets total   1.1 1.7 1.2 1.1 0.9 0.9 0.0 0.0   Shareholders equity total   55.1 53.7 32.6 44.3 50.9 41.7 41.0 41.0   Interest-bearing liabilities   162 148 184 103 38.4 49.1 0.0 0.0   Balance sheet total (assets)   279 389 374 260 225 207 41.0 41.0   Net Debt   82.5 105 -20.7 33.1 -59.3 -45.1 -41.0 -41.0     See the entire balance sheet 1.0 Volume  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   154 354 370 319 251 288 288 288   Net sales growth   -33.5% 129.4% 4.4% -13.8% -21.3% 14.6% 0.0% 0.0%   Gross profit   29.7 50.3 61.9 67.4 53.1 38.4 0.0 0.0   Gross profit growth   -29.5% 69.5% 23.1% 8.8% -21.2% -27.7% -100.0% 0.0%   Employees   0 0 0 50 48 48 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -4.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   279 389 374 260 225 207 41 41   Balance sheet change%   38.7% 39.4% -3.9% -30.5% -13.4% -7.8% -80.2% 0.0%   Added value   12.9 21.7 27.2 36.7 27.8 13.5 0.0 0.0   Added value %   8.3% 6.1% 7.3% 11.5% 11.1% 4.7% 0.0% 0.0%   Investments   0 1 -0 -0 -0 -0 -1 0   Net sales trend   -1.0 1.0 2.0 -1.0 -2.0 1.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A EBITDA %   8.3% 6.1% 7.3% 11.5% 11.1% 4.7% 0.0% 0.0%   EBIT %   8.3% 6.1% 7.3% 11.5% 11.1% 4.7% 0.0% 0.0%   EBIT to gross profit (%)   43.4% 43.2% 43.9% 54.4% 52.4% 35.1% 0.0% 0.0%   Net Earnings %   4.1% 4.5% 6.3% 8.9% 8.8% 4.7% 0.0% 0.0%   Profit before depreciation and extraordinary items %   4.1% 4.5% 6.3% 8.9% 8.8% 4.7% 0.0% 0.0%   Pre tax profit less extraordinaries %   4.9% 5.8% 8.1% 11.4% 11.4% 6.2% 0.0% 0.0%   ROA %   5.9% 6.7% 7.9% 11.8% 12.0% 8.4% 0.0% 0.0%   ROI %   7.5% 10.3% 13.5% 19.2% 22.9% 18.8% 0.0% 0.0%   ROE %   10.2% 29.4% 54.3% 73.8% 46.2% 28.9% 0.0% 0.0%   1.0 Solidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Equity ratio %   19.8% 13.8% 8.7% 17.0% 22.6% 20.1% 100.0% 100.0%   Relative indebtedness %   141.4% 91.2% 87.8% 64.8% 66.5% 55.4% 0.0% 0.0%   Relative net indebtedness %   90.2% 79.0% 32.3% 42.7% 27.6% 22.7% -14.2% -14.2%   Net int. bear. debt to EBITDA, %   640.7% 482.1% -76.3% 90.2% -213.1% -334.4% 0.0% 0.0%   Gearing %   293.0% 275.8% 564.9% 233.7% 75.4% 117.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.4% 1.1% 0.1% 0.8% 0.5% 0.8% 0.0% 0.0%   1.0 Liquidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Quick Ratio   1.1 1.0 1.0 1.1 1.4 1.2 0.0 0.0   Current Ratio   1.3 1.2 1.1 1.3 1.5 1.4 0.0 0.0   Cash and cash equivalent   79.0 43.4 205.0 70.4 97.7 94.2 0.0 0.0   1.0 Capital use efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Trade debtors turnover (days)   215.7 70.2 13.2 64.1 120.8 86.3 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   179.5% 109.1% 100.6% 81.0% 89.1% 71.8% 14.2% 14.2%   Net working capital   58.9 63.4 47.4 56.3 78.5 60.5 0.0 0.0   Net working capital %   38.1% 17.9% 12.8% 17.7% 31.3% 21.0% 0.0% 0.0%   1.0 Employee efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales / employee   0 0 0 6 5 6 0 0   Added value / employee   0 0 0 1 1 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 1 1 0 0 0   EBIT / employee   0 0 0 1 1 0 0 0   Net earnings / employee   0 0 0 1 0 0 0 0